Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG et al. > Summary
Court Case Number IPR2020-01317
Filing Date Jul 16, 2020
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesRobert L. Kinder, Erica A. Franklin, Kristi L. R. Sawert
Judge Writing the Final DecisionRobert L. Kinder
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
Petitioner
Patent Owner
Petitioner Attorneys
9Regeneron Pharmaceuticals
Attorney Name: Christopher M. Pepe
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Natalie Carol Kennedy
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Andrew P. Gesior
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Timothy J. Andersen
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Brian E. Ferguson
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Anish R. Desai
Weil, Gotshal & Manges
Regeneron Pharmaceuticals
Attorney Name: Horst Koller
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Attorney Name: James Agalloco
Regeneron Pharmaceuticals
Patent Owner Attorneys
6NOVARTIS PHARMA AG
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP
NOVARTIS PHARMA AG
Attorney Name: William G. James
Goodwin Procter LLP
NOVARTIS PHARMA AG
Attorney Name: Linnea P. Cipriano
Goodwin Procter LLP
NOVARTIS PHARMA AG
Attorney Name: Michael P. Mazza
Novartis
NOVARTIS PHARMA AG
Attorney Name: Daniel J. Woods
Novartis
NOVARTIS PHARMA AG
Attorney Name: Joshua S. Weinger
Goodwin Procter LLP
Related Patents
Doc No | Title | Issue date |
---|---|---|
09220631 | Syringe | Dec 29, 2015 |